This article was published more than 2 years agoCommentGift ShareThe leader of the White House’s effort to develop a coronavirus vaccine has predicted that by the end of January, there will be a “significant decrease” in deaths among the nation’s elderly, as high-risk populations in the United States receive vaccinations.Moncef Slaoui, chief science adviser to Operation Warp Speed, said he expects independent advisers to the Food and Drug Administration to recommend emergency authorization for the vaccine developed by Pfizer and German biotechnology company BioNTech when the panel...…This article was published more than 2 years agoCommentGift ShareThe leader of the White House’s effort to develop a coronavirus vaccine has predicted that by the end of January, there will be a “significant decrease” in deaths among the nation’s elderly, as high-risk populations in the United States receive vaccinations.Moncef Slaoui, chief science adviser to Operation Warp Speed, said he expects independent advisers to the Food and Drug Administration to recommend emergency authorization for the vaccine developed by Pfizer and German biotechnology company BioNTech when the panel...WW…